5 research outputs found
The effect of combined glutamate receptor blockade in the NTS on the hypoxic ventilatory response in awake rats differs from the effect of individual glutamate receptor blockade.
Ventilatory acclimatization to hypoxia (VAH) increases the hypoxic ventilatory response (HVR) and causes persistent hyperventilation when normoxia is restored, which is consistent with the occurrence of synaptic plasticity in acclimatized animals. Recently, we demonstrated that antagonism of individual glutamate receptor types (GluRs) within the nucleus tractus solitarii (NTS) modifies this plasticity and VAH (J. Physiol. 592(8):1839-1856); however, the effects of combined GluR antagonism remain unknown in awake rats. To evaluate this, we exposed rats to room air or chronic sustained hypobaric hypoxia (CSH, PiO2 = 70 Torr) for 7-9 days. On the experimental day, we microinjected artificial cerebrospinal fluid (ACSF: sham) and then a "cocktail" of the GluR antagonists MK-801 and DNQX into the NTS. The location of injection sites in the NTS was confirmed by glutamate injections on a day before the experiment and with histology following the experiment. Ventilation was measured in awake, unrestrained rats breathing normoxia or acute hypoxia (10% O2) in 15-min intervals using barometric pressure plethysmography. In control (CON) rats, acute hypoxia increased ventilation; NTS microinjections of GluR antagonists, but not ACSF, significantly decreased ventilation and breathing frequency in acute hypoxia but not normoxia (P < 0.05). CSH increased ventilation in hypoxia and acute normoxia. In CSH-conditioned rats, GluR antagonists in the NTS significantly decreased ventilation in normoxia and breathing frequency in hypoxia. A persistent HVR after combined GluR blockade in the NTS contrasts with the effect of individual GluR blockade and also with results in anesthetized rats. Our findings support the hypotheses that GluRs in the NTS contribute to, but cannot completely explain, VAH in awake rats
Inhibitors of the Thioesterase Activity of <i>Mycobacterium tuberculosis</i> Pks13 Discovered Using DNA-Encoded Chemical Library Screening
DNA-encoded chemical library (DEL) technology provides
a time-
and cost-efficient method to simultaneously screen billions of compounds
for their affinity to a protein target of interest. Here we report
its use to identify a novel chemical series of inhibitors of the thioesterase
activity of polyketide synthase 13 (Pks13) from Mycobacterium
tuberculosis (Mtb). We present three chemically distinct
series of inhibitors along with their enzymatic and Mtb whole cell
potency, the measure of on-target activity in cells, and the crystal
structures of inhibitor-enzyme complexes illuminating their interactions
with the active site of the enzyme. One of these inhibitors showed
a favorable pharmacokinetic profile and demonstrated efficacy in an
acute mouse model of tuberculosis (TB) infection. These findings and
assay developments will aid in the advancement of TB drug discovery
Inhibitors of the Thioesterase Activity of <i>Mycobacterium tuberculosis</i> Pks13 Discovered Using DNA-Encoded Chemical Library Screening
DNA-encoded chemical library (DEL) technology provides
a time-
and cost-efficient method to simultaneously screen billions of compounds
for their affinity to a protein target of interest. Here we report
its use to identify a novel chemical series of inhibitors of the thioesterase
activity of polyketide synthase 13 (Pks13) from Mycobacterium
tuberculosis (Mtb). We present three chemically distinct
series of inhibitors along with their enzymatic and Mtb whole cell
potency, the measure of on-target activity in cells, and the crystal
structures of inhibitor-enzyme complexes illuminating their interactions
with the active site of the enzyme. One of these inhibitors showed
a favorable pharmacokinetic profile and demonstrated efficacy in an
acute mouse model of tuberculosis (TB) infection. These findings and
assay developments will aid in the advancement of TB drug discovery